Clinical Trial Update: Proteomics Study of Gastric Bypass Surgery to Treat Type 2 Diabetes Mellitus

View source ↗

Summary

This entry describes a clinical trial investigating proteomic changes associated with gastric bypass surgery as a treatment for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: No. 150 Central Hospital of the Chinese People Liberation Army | Conditions: Type 2 Diabetes | Status: UNKNOWN